Pular para o conteúdo
Menu
Mix Vale

Experimental drug for lung condition reveals unexpected potential to reduce biological age markers

Luís Pereira
Por 5 min de leitura
Compartilhe

A medication under development to combat a severe lung ailment has shown an unforeseen capacity to potentially decelerate the biological aging process, according to recent findings from a preliminary clinical study. Patients administered with rentosertib, an investigational drug, exhibited measurable alterations in their blood protein profiles that correlated with a biologically younger state.

Publicidade

The study, which involved a small group of participants, suggested that individuals treated with the compound appeared, on average, three to four years younger biologically, with some instances showing an effect of up to six years. These surprising results were presented at a Nature conference at Sorbonne University in Paris and published in Nature Biotechnology, sparking interest in the drug’s broader implications beyond its primary therapeutic target.

A serendipitous discovery in clinical trials

Rentosertib, developed by Insilico Medicine, a Massachusetts-based biotechnology firm, was initially designed to treat idiopathic pulmonary fibrosis (IPF). IPF is a debilitating condition characterized by progressive scarring of the lungs, leading to severe breathing difficulties and a grim prognosis. The drug’s development leveraged artificial intelligence to identify specific molecular targets, a process that Insilico Medicine founder and co-CEO Alex Zhavoronkov, PhD, refers to as pinpointing “molecular criminals” that contribute to both aging and disease.

Publicidade

During the clinical evaluation, researchers observed an unexpected pattern in the blood work of patients receiving rentosertib. Multiple validated biological aging tests consistently indicated that these patients “scored” biologically younger compared to those who received a placebo. This intriguing side effect, described as a “bonus” by Dr. Zhavoronkov, has opened new avenues for understanding the complex interplay between disease treatment and the aging continuum.

Measuring biological age: The scientific approach

The assessment of biological age in the study relied on analyzing changes in specific blood proteins. Researchers compared these protein patterns to data from over 55,000 individuals within the UK Biobank, revealing that rentosertib shifted several blood proteins in a direction opposite to what is typically observed with natural aging. This suggests a potential impact on fundamental cellular processes.

The most pronounced effects were noted after four weeks of treatment in patients receiving a specific dosage of the drug twice daily. Beyond blood protein analysis, the study also found indications that rentosertib might influence aging at a cellular level, by modifying processes crucial for cellular function and their response to damage. This multi-faceted evidence, though preliminary, underscores the potential for interventions that could address aging at its biological roots.

AI’s role in identifying ‘molecular criminals’ and future steps

The discovery of rentosertib’s anti-aging potential highlights the growing role of artificial intelligence in drug development. AI algorithms were instrumental in identifying the biological targets for the drug, accelerating the process of bringing a novel compound from concept to clinical trial. Dr. Zhavoronkov emphasizes that this approach allows for the identification of molecular pathways that are implicated in both age-related diseases and the aging process itself.

Despite the promising findings, researchers maintain a cautious stance. They stress that these results are preliminary and do not yet confirm that rentosertib can truly reverse aging or extend human lifespan. The drug remains investigational, and further, more extensive trials are crucial to validate these initial observations. The current study involved a limited sample size of 42 patients over a 12-week period, and all participants suffered from IPF, a condition that itself can influence the very proteins used to measure biological aging. This raises the possibility that improvements in lung disease might be linked to the observed protein changes.

Publicidade

Cautious optimism and the broader implications for longevity research

The safety profile of rentosertib in the initial study was deemed manageable. Dr. Carol Ann Satler, senior vice president of clinical development for Insilico Medicine, noted that potential side effects were generally mild and reversible upon discontinuation of the drug. These included:

  • Mild diarrhea.
  • Slightly decreased potassium levels in the blood.
  • Temporary elevations in liver enzymes.

The drug has now advanced to a year-long phase 3 study involving over 300 patients in China. Future research will require larger and longer trials, ideally including healthy older adults and populations without IPF, to definitively determine if rentosertib possesses genuine anti-aging effects and whether these could translate into tangible health benefits and extended longevity. While the journey is long, the initial findings have bolstered confidence in pursuing drugs that could target both age-related diseases and the fundamental mechanisms of aging, aligning with the vision that “living longer should be a fundamental human right for everyone,” as articulated by Dr. Zhavoronkov.

Publicidade

Luís Henrique Costa é jornalista formado pela FMU, editor-chefe e fundador do Mix Vale, portal de notícias em atividade desde 2011. Responde pela direção editorial do veículo, que cobre Brasil e mundo em economia, benefícios sociais, esportes, tecnologia, ciência e entretenimento. Atua na área há mais de 15 anos e lidera uma equipe de cerca de 15 colaboradores.

Notícias relacionadas

Mais lidas

  1. Ciência

    Meteoro no Nordeste: bólido cruza o céu de cinco estados às 21h34 e mobiliza buscas por fragmentos na Paraíba

  2. Caixa Econômica Federal

    Pé-de-Meia paga parcela de R$ 1.000,00 a aprovados no ensino médio de 2026 entre fevereiro e março de 2027

  3. Política

    Com obstrução parcial no intestino, Jair Bolsonaro é internado no hospital DF Star em Brasília

  4. INSS

    Recuperação da senha Gov.br pelo celular exige reconhecimento facial ou código por SMS para o Meu INSS

  5. EUA

    Terremoto em Los Angeles atinge magnitude 4,2 e causa tremores leves em Commerce na madrugada

  6. Matéria Publicitária

    MineMV é o novo jogo grátis de construir com blocos; veja como jogar e liberado para todas as idades

  7. Política

    Regulamentação da escala 5×2 pelo governo encarece cálculo da hora extra a partir de 16 de dezembro

  8. Santa Catarina

    Acidente de trânsito na SC-108 envolve carro e moto e deixa motociclista morto em São Ludgero

  9. Mundo

    Jornalista italiano Corrado Augias morre aos 91 anos; presidente da Itália lamenta a perda

  10. Loterias

    Rendimento de R$ 40 milhões da Mega-Sena 3088 chega a R$ 337 mil por mês no Tesouro Direto